Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

NCT00097695 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Angioedema

Interventions

DRUG: Icatibant
DRUG: Placebo

Sponsor

Shire